BUHLMANN Diagnostics Corp
BUHLMANN Diagnostics Corp (BDC), Amherst NH is the North American affiliate of BÜHLMANN Laboratories AG, a leading worldwide operative manufacturer of ELISA kits, RIA kits, lateral flow assay kits, flow cytometry assay kits and turbidimetric assays kits. Located in a state-of-the-art facility in Southern New Hampshire, the BDC team collectively represents over 100 years of experience in serving both clinical and basic science research laboratories.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Monitoring
- Market Focus:
- Globally (various continents)
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
BUHLMANN Diagnostics Corp (BDC) is the North American affiliate of BÜHLMANN Laboratories AG, a leading worldwide operative manufacturer of ELISA kits, RIA kits, lateral flow assay kits, flow cytometry assay kits and turbidimetric assay kits. Located in a state-of-the-art facility in Southern New Hampshire, the BDC team collectively represents over 100 years of experience in serving both clinical and basic science research laboratories.
BÜHLMANN offers the broadest calprotectin product range in the industry including BÜHLMANN fCAL® turbo, BÜHLMANN fCAL® ELISA and quantitative Quantum Blue® Calprotectin rapid tests. All calprotectin products benefit from our patented easy, safe, and clean stool CALEX® sampling and extraction devices.
Beyond our calprotectin brand, we also offer a selection of unique, high-quality assays for Cellular Allergy testing such as the BÜHLMANN Flow CAST® product group for Basophil Activation Testing and Neuroimmunology testing such as the BÜHLMANN GanglioCombi™ products; the only screening ELISAs for anti-Ganglioside testing. Other areas of BÜHLMANN’s focus include specialized niche products for Clinical Chemistry (ACE, GHB, etc.) as well as the first- to-market Chronobiology melatonin line of assays. BÜHLMANN continues to renew and enlarge its product portfolio, with the aim to be a leader in selected fields of in vitro diagnostics and scientific research by combining innovation with traditional core values of quality products and superior service to our customers.
BÜHLMANN is unique, independent, and reliable in every aspect of its business from the outstanding quality of products, excellent after-sales services, and remarkable scientific innovations. The establishment of BDC is a statement of the importance of you, our customers and our commitment to understanding your needs. Our North American affiliate will help us to continue to foster closer relationships with our customers and enhance our customer support interactions as well as meet your requirements for future BÜHLMANN products. Quality is not just a statement, but part of our daily mission.
Quality Statement
BÜHLMANN is ISO 13485 certified!
BÜHLMANN Laboratories AG is proud to announce the achievement of EN ISO 13485:2016 and MDSAP certification for our Quality Management System, demonstrating our commitment to the quality of our IVD products.
Our process controls, documentation, and quality standards meet or exceed all ISO 13485 requirements. By this, our customers can expect a constant and high level of reliability and transparency from our work. The quality of our products and services is supported by every employee.
The Quality Management System is additionally based on the requirements of US Quality Systems Regulations (21 CFR 820), and the Canadian Regulations (SOR/98-282), as well as the applicable GMP requirements.
Certification is proof of quality. It also provides an advantage for you, our customers. Because of certifications, you can easily distinguish between higher quality and lower quality suppliers of IVD products.
What is EN ISO 13485:2016 + MDSAP:
ISO 13485:2016 and MDSAP certification specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer requirements and regulatory requirements applicable to medical devices and related services.